In New York City, the fast pace and constant pressure can exacerbate Depression—especially for those who’ve tried multiple antidepressants with limited success. That’s why we’ve built out a Spravato medication
New Hope for NYC: Esketamine for Anxiety and Comorbid Treatment-Resistant Depression
Depression is widespread—and even more so in high-stress environments like New York City. Despite advances in treatment, many patients—especially those contending with treatment-resistant Depression (TRD) and comorbid anxiety–find that standard
Spravato NYC: A Breakthrough Nasal Spray for Treatment-Resistant Depression
When Depression Doesn’t Respond—Hope Still Exists with the Spravato Treatment NYC Citizens Need If you’ve been living in New York City and struggling with Depression that just won’t lift, even
Understanding the Paradoxical Effect of Antidepressants
Over the years, countless patients have turned to antidepressants as a definitive answer to their complex psychological challenges. In recent years, however, researchers have continued to question conventional wisdom by
Beyond Antidepressants: Why TMS May Be the Best Next Step in Battling Symptoms of Depression in Older Adults
For many older adults, Depression is more than just sadness. It can be persistent, debilitating, and resistant to standard treatment. In fact, a significant number of adults over the age
Could Ozempic Be Used for Mental Health Treatment? Learn About GLP-1 Drugs
GLP-1 medications like Ozempic and Wegovy show promise in treating Depression, addiction, and cognitive issues. But what are GLP-1 drugs exactly, how do they work, what promise and results have
When Antidepressants Stop Working: An Update on “Poop Out”
Antidepressants have brought relief to millions of people struggling with major depressive disorder (MDD). They can restore energy, stabilize mood, and allow patients to reclaim parts of their lives that
Does Ketamine Improve Quality of Life for People with Depression?
When you hear the word “ketamine,” you might think of club drugs or even anesthesia. But in recent years, ketamine—and its close cousin, esketamine (Spravato)—has been receiving much attention in
Depression and Cardiovascular Disease
Depression and cardiovascular disease (CVD) are two of the most pervasive and disabling health conditions globally—and mounting evidence shows that they are deeply interconnected. Heart disease continues to be the
Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe
Treatment-resistant Depression (TRD) poses a significant challenge in mental health care. Despite the availability of various antidepressant therapies, a substantial subset of patients fails to achieve response or remission, leading